≡
  1. Antibodies

Summary:

Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

PAA794Hu01 | Homo sapiens (Human)

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

PAA794Mu01 | Mus musculus (Mouse)

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

PAA794Mu02 | Mus musculus (Mouse)

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

PAA794Ra01 | Rattus norvegicus (Rat)

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
1/1